Tokyo Ohka Kogyo stock rating downgraded to Neutral by UBS despite price target hike

UBS downgraded Tokyo Ohka Kogyo (4186:JP) from Buy to Neutral while raising its price target to JPY6,200 from JPY5,000 after Q3 results, citing stronger AI-related semiconductor demand and boosting its FY12/26 forecasts to sales of ¥250.4bn (up 7.5% YoY) and operating profit of ¥50.0bn (up 14.2%). The bank expects EUV resist sales to rise 25% YoY and ArF/KrF resists about 10% each, with bump resist volumes up roughly 20%, driven by front-end photoresists for advanced nodes and back-end packaging materials, though Tokyo Ohka has limited share in 3nm EUV resists. The revision underscores improved earnings momentum from AI-driven demand but reflects UBS's view that valuation upside is now more constrained given competitive risks at leading-edge nodes.

Analysis

UBS downgraded Tokyo Ohka Kogyo from Buy to Neutral while raising its price target to JPY6,200 from JPY5,000 after Q3 results, and the bank revised FY12/26 sales to ¥250.4 billion (a 7.5% year-over-year increase) and operating profit to ¥50.0 billion (a 14.2% YoY rise). These upward revisions reflect UBS's view of stronger AI-related semiconductor demand supporting demand for Tokyo Ohka's materials.

UBS identifies front-end photoresists for advanced nodes and back-end packaging materials as the primary earnings drivers, forecasting EUV resist sales to grow 25% YoY, ArF and KrF resists about 10% each, and bump resist volumes up roughly 20% YoY. The firm nevertheless flags that Tokyo Ohka has minimal market share in 3nm-generation EUV resists while expecting steadier shipment growth at 2nm and 4/5nm nodes, highlighting node-specific competitive constraints.

The rating shift signals UBS believes fundamentals have improved but that valuation upside is now more constrained by competitive risk at leading-edge nodes; consensus impact is mildly positive with limited market disruption. Key near-term risks are execution on EUV share gains, preservation of margin expansion, and confirmation of the projected volume ramps that underpin the upgraded FY12/26 guidance.

Key Decisions for Investors

• Treat existing positions as hold or consider modest trimming rather than adding new exposure given UBS's Neutral rating despite a higher JPY6,200 target
• Watch quarterly shipment, revenue and margin disclosure specifically for EUV resist sales versus UBS's +25% FY12/26 outlook and bump resist volume trends for confirmation of AI-driven demand
• Reassess accumulation only if company reports clear 3nm/leading-edge share gains or sustained margin improvement that materially increases upside to the revised price target